How to run a meeting at an academic medical center
🧵
Originally, this presentation was for our oncology trainees, and we figured we would share it on #AcademicTwitter#MedTwitter to maximize the impact of your meetings.
3. Before the meeting, send an agenda and minutes from last meeting.
Make your meetings friendly for those who may be calling in from their phone or Zoom app: send link, password, etc.
4. Start on time. 5. Designate someone to record the minutes. 6. Assume no one read the agenda you sent, and encourage everyone to participate.
7. During the meeting, use an agenda to keep guests on task and on time.
Consider the "Ds":
FYI / for declaration
For discussion
For decision
Future direction
8. During the meeting, steer the conversation.
The host can lead the discussion, minimize interruptions, pause the group, encourage constituents to speak.
9. Do not deviate from the purpose.
A frequent set of meetings that may deviate from their goals are the SRC, IRB, and DSMB.
Each of these meetings has a unique purpose for clinical trials.
10. If you speak up and identify a problem, propose a solution.
This works for other discussions with senior leaders too. A leader may not understand the problem and possible solutions until you tell them.
11. At the conclusion of the meeting, the host should summarize core points and make an action list.
"What will we do by when?"
If your action list includes things like sending emails, send them before you leave the meeting.
What are the arguments for and against the combination of conventionally fractionated radiotherapy (2 Gy / fx; ~10-45 fractions) with concurrent immunotherapy (ipi, nivo, etc)?
Proponents of combination therapy will reference:
1, numerous studies of RT + ICI, all seemingly safe
2, ICI is the best option if cisplatin ineligible
3, RT is immunostimulatory, should boost effect of ICI, RT + ICI is synergistic
Counterargument to #1:
Yes, there are data on toxicity, but almost all studies use SBRT/SRS, ie, > ~5 Gy per fraction x 1-5 fractions (not 2 Gy). There are limited mature studies on efficacy.
Meta-analysis from @PennStHershey MD PhD student Mike Sha: